 |
 |
 |
 |
 | ||||
 | ||||||||
|
medical devices AngioScore, Inc. is developing a novel line of angioplasty catheters for use in treatment of cardiovascular and peripheral vascular diseases. The catheters address the many clinical challenges associated with existing balloon products, improving the deployment of drug-eluting stents through enhanced vessel preparation, and providing safe and effective treatment options for complex and difficult-to-open vessels. In addition, the AngioSculptTM catheter is designed to provide substantially better deliverability and safety as compared to alternative, higher-cost competing products. The AngioSculptTM scoring catheter has the potential to improve the results of as many as half of the 2.4 million angioplasties performed worldwide annually. BioVentrix, Inc. BioVentrix was formed to deliver best-of-breed solutions to cure the now epidemic problem of congestive heart failure. BioVentrix is focused on developing surgical devices that will improve existing LVR procedures, and developing new surgical therapies for CHF. This will include utilizing BioVentrix’s expertise in minimally invasive heart surgery to develop totally endoscopic and percutaneous approaches and methods. Endoscopic Technologies, Inc. is a medical device company focused on the development and sale of products primarily for use in minimally invasive cardiovascular surgery. Estech's products are intended to enable the least invasive surgical approaches that have the fastest potential recovery time and lowest rate of complications, at the lowest cost for these life-saving procedures. The company's primary product lines are targeted for use in beating heart coronary artery bypass graft procedures and for the treatment of atrial fibrillation. InSound Medical, Inc. is a medical device company focused on the development and sale of next generation hearing aid solutions. InSound's products, and the intellectual property that support them, are designed to address the traditional shortcomings of hearing aids by providing the 70 million hearing-impaired individuals worldwide with extended-wear, disposable products that have superior sound quality and durability. SpineMatrix, Inc.
(SMI)
is a spinal imaging company that has developed CERSR® for evaluating low back physiology related to the origin of
lower back pain (LBP) and injury. CERSR aids the physician in accurately diagnosing the true source of LBP with the
very real potential to significantly reduce total health care costs by directing the patient to the appropriate
diagnostic and therapeutic procedures. CERSR has FDA approval and is reimbursable. SMI has completed clinical efficacy
studies at The Cleveland Clinic, the Texas Back Institute, Ohio State University College of Medicine and others on
muscle, facet and disc pathology. Analysis of the data showed CERSR is clearly able to differentiate the source of LBP
and which patients will respond to certain forms of treatment..
VeraLight, headquartered in Albuquerque, New Mexico is a medical instrumentation company that was established in 2004 as an independent spinout of InLight Solutions, a company focused on light-based medical devices.
VeraLight is focused on a comprehensive approach to non-invasive diabetes screening. The company’s mission is to help stem the tide of the worldwide diabetes epidemic through early diabetes detection, thus enabling initiation of therapies that can prevent diabetes or reduce its complications.
|
| ||||||
 | ||||||||
 | ||||||||
| ||||||||
